Cargando…
A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease
BACKGROUND: Cardiovascular events are the leading cause of death in end stage renal disease (ESRD). Adherence to phosphate binding medication plays a vital role in reducing serum phosphorus and associated cardiovascular risk. This poses a challenge for patients as the regimen is often complex and th...
Autores principales: | Karamanidou, Christina, Clatworthy, Jane, Weinman, John, Horne, Rob |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270809/ https://www.ncbi.nlm.nih.gov/pubmed/18237373 http://dx.doi.org/10.1186/1471-2369-9-2 |
Ejemplares similares
-
Medication nonadherence and psychiatry
por: Chapman, Sarah C.E., et al.
Publicado: (2013) -
Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease
por: Chang, Po-Ya, et al.
Publicado: (2015) -
Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels
por: Kitamura, Mineaki, et al.
Publicado: (2019) -
The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence
por: Chan, Amy Hai Yan, et al.
Publicado: (2020) -
What Are the Factors Associated with Nonadherence to Medications in Patients with Chronic Diseases?
por: Al Bawab, Abdel Qader, et al.
Publicado: (2021)